TriKEs and BiKEs join CARs on the cancer immunotherapy highway

Unprecedented clinical success has recently been achieved in cancer immunotherapy using cytotoxic T cells armed with activating tumor-specific Chimeric Antigen Receptors (CARs). Natural killer (NK) cells, potent cytotoxic effectors, also hold potential to be effectively harnessed for immunotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Szun Szun, Carol, Hernan, Biro, Maté
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137511/
https://www.ncbi.nlm.nih.gov/pubmed/27322989
http://dx.doi.org/10.1080/21645515.2016.1198455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137511/
https://www.ncbi.nlm.nih.gov/pubmed/27322989
http://dx.doi.org/10.1080/21645515.2016.1198455

Ejemplares similares